See all our PhD projects:

Fully-funded PhD projects

Apply for our fully-funded PhD projects in subjects including chemistry, biology, computer science, and physics.

PhD opportunities for science graduates

We are now accepting applications for our 2025/2026 PhD studentships and the projects can be browsed below. You will also find a link to further information about our application process and our mailing list, should you wish to be notified about future PhD opportunities.

Stipends

The ICR's current student stipend is £26,505 per year. Studentships awarded by the Cancer Research UK Convergence Science Centre, which is a partnership of the ICR and Imperial College London, instead includes a stipend paid at the Cancer Research UK rate of £24,219 per year.

Find out about our application process  Mailing list

Available opportunities

You can view details of the 2025/2026 projects below. 

Funding for our PhD projects comes from a variety of different sources, including some funded programmes, such as the MRC Doctoral Training Partnership and the CRUK Science Centre at the ICR and Imperial.  

Please note, the advertised funder may change prior to registration.

 

 

Typos in the genome: Defining the molecular mechanism of replication slippage

Primary supervisor: Dr Gideon Coster Primary site: Chelsea Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Typos in the genome: Defining the molecular mechanism of replication slippage

See full project details

Towards non-invasive monitoring and prediction of cancer evolutionary dynamics from cfDNA

Primary supervisor: Professor Trevor Graham Primary site: Sutton Funded by Horizon Europe MSCA Doctoral Network 2025

Towards non-invasive monitoring and prediction of cancer evolutionary dynamics from cfDNA

See full project details

The Role of Early Plasma Cell Infiltration in Breast Cancer Immune Responses

Primary supervisor: Dr Esther Arwert Primary site: Chelsea Funded by ICR

The Role of Early Plasma Cell Infiltration in Breast Cancer Immune Responses

See full project details

The Multiscale Vulnerability Map: Cross-Discipline Multimodal Mining Reveals Colorectal Cancer's Hidden Weak Points

Primary supervisor: Professor Anguraj Sadanandam Primary site: Sutton Funded by MRC iCASE Award (Merck)

The Multiscale Vulnerability Map: Cross-Discipline Multimodal Mining Reveals Colorectal Cancer's Hidden Weak Points

See full project details

Targeting Urea Cycle Dysregulation as a Tumour Specific Vulnerability in Lethal Prostate Cancer

Primary supervisor: Dr Alec Paschalis Primary site: Sutton Funded by ICR

Targeting Urea Cycle Dysregulation as a Tumour Specific Vulnerability in Lethal Prostate Cancer

See full project details

Targeting AMPK as a metabolic vulnerability of metastatic cancer cells

Primary supervisor: Professor Joanna Loizou Primary site: Sutton Funded by ICR

Targeting AMPK as a metabolic vulnerability of metastatic cancer cells

See full project details

Redox control of DNA replication: how mitochondrial ROS tune replisome function to preserve genome stability

Primary supervisor: Dr Jörg Mansfeld Primary site: Chelsea Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Redox control of DNA replication: how mitochondrial ROS tune replisome function to preserve genome stability

See full project details

Overcoming oncogenic androgen receptor signalling to transform the care of lethal prostate cancer

Primary supervisor: Dr Adam Sharp Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Overcoming oncogenic androgen receptor signalling to transform the care of lethal prostate cancer

See full project details

New strategies for exploiting the fitness costs of drug resistance in cancer

Primary supervisor: Professor Trevor Graham Primary site: Sutton Funded by Horizon Europe MSCA Doctoral Network 2025

New strategies for exploiting the fitness costs of drug resistance in cancer

See full project details

Folate-Degrader Conjugates (FDCs) for Tumour-specific Targeting

Primary supervisor: Professor Zoran Rankovic Primary site: Sutton Funded by MRC iCASE award (AstraZeneca)

Folate-Degrader Conjugates (FDCs) for Tumour-specific Targeting

See full project details

Exploiting lineage-specific dependencies in paediatric-type diffuse high-grade glioma.

Primary supervisor: Professor Chris Jones Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Exploiting lineage-specific dependencies in paediatric-type diffuse high-grade glioma.

See full project details

Enhancer-Gene Networks as Therapeutic Targets in Multiple Myeloma

Primary supervisor: Professor Martin Kaiser Primary site: Sutton Funded by ICR

Enhancer-Gene Networks as Therapeutic Targets in Multiple Myeloma

See full project details

Enabling Oral Delivery of VHL-based PROTACs Through Formulation and Prodrug Design

Primary supervisor: Professor Swen Hoelder Primary site: Sutton Funded by MRC iCASE CRODA Pharma

Enabling Oral Delivery of VHL-based PROTACs Through Formulation and Prodrug Design

See full project details

Elucidation of the molecular basis for the chaperoning of DEAH-box RNA helicases by the oncoprotein and cochaperone NudCD1

Primary supervisor: Dr Rob Van Montfort Primary site: Chelsea & Sutton Funded by ICR

Elucidation of the molecular basis for the chaperoning of DEAH-box RNA helicases by the oncoprotein and cochaperone NudCD1

See full project details

Development of the next generation circulating tumour DNA tests in gastrointestinal cancers

Primary supervisor: Professor Michael Hubank Primary site: Sutton Funded by NIHR

Development of the next generation circulating tumour DNA tests in gastrointestinal cancers

See full project details

Deciphering cancer cell dependency on eIF4E

Primary supervisor: Dr Paul Clarke Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Deciphering cancer cell dependency on eIF4E

See full project details